Macquarie Group’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-19,797
| Closed | -$3.27M | – | 2707 |
|
|
2021
Q2 | $3.27M | Sell |
19,797
-2,232
| -10% | -$373K | ﹤0.01% | 1260 |
|
|
2021
Q1 | $3.38M | Buy |
22,029
+2,251
| +11% | +$306K | ﹤0.01% | 1017 |
|
|
2020
Q4 | $2.48M | Buy |
19,778
+16,912
| +590% | +$1.89M | ﹤0.01% | 1041 |
|
|
2020
Q3 | $291K | Hold |
2,866
| – | – | ﹤0.01% | 1525 |
|
|
2020
Q2 | $279K | Sell |
2,866
-134
| -4% | -$12.5K | ﹤0.01% | 1473 |
|
|
2020
Q1 | $249K | Hold |
3,000
| – | – | ﹤0.01% | 1406 |
|
|
2019
Q4 | $333K | Sell |
3,000
-900
| -23% | -$92.6K | ﹤0.01% | 1483 |
|
|
2019
Q3 | $387K | Hold |
3,900
| – | – | ﹤0.01% | 1429 |
|
|
2019
Q2 | $387K | Buy |
+3,900
| New | +$372K | ﹤0.01% | 1409 |
|
|
2019
Q1 | – | Sell |
-100
| Closed | -$9K | – | 2202 |
|
|
2018
Q4 | $9K | Buy |
+100
| New | +$10.1K | ﹤0.01% | 1952 |
|
|
2017
Q4 | – | Sell |
-400
| Closed | -$30K | – | 2473 |
|
|
2017
Q3 | $30K | Buy |
+400
| New | +$30.2K | ﹤0.01% | 2061 |
|
|
2017
Q2 | – | Sell |
-8,750
| Closed | -$571K | – | 1567 |
|
|
2017
Q1 | $571K | Buy |
+8,750
| New | +$515K | ﹤0.01% | 1302 |
|
Other funds holding PRAH
Macquarie Group's PRAH Position: Q3 2021 in Review
Macquarie Group sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 19,797 shares — an estimated $3.27M sold.
Macquarie Group first reported a position in PRAH in Q1 2017 and held it in 12 quarters. The position peaked at $3.38M in Q1 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- Macquarie Group reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Macquarie Group sold 19,797 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $3.27M.
- Macquarie Group first reported a position in PRA Health Sciences, Inc. in Q1 2017 and held it in 12 quarters.
- Macquarie Group's PRA Health Sciences, Inc. position peaked at $3.38M in Q1 2021.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on Macquarie Group's 13F filing for Q3 2021, filed 12 Nov 2021.